Shire UK currently focuses on the following therapeutic areas:
Attention Deficit Hyperactivity Disorder (ADHD),
Essential Thrombocythaemia, Gaucher's
Angioedema, Hunter Syndrome,
Chronic Kidney Disease,
Ulcerative Colitis, and
Seizures and Epilepsy.
Shire UK is a market leader in providing adjunctive therapies for patients
with osteoporosis through our
range of calcium-based supplements.
Shire UK brings the same focus and dedication to
gastrointestinal and renal (kidney)
diseases, with products for the treatment of mild to moderate ulcerative
colitis, a type of inflammatory bowel disease, and a phosphate binder for use in
some patients with chronic kidney disease.
Through the commitment of our employees, we are making a difference to
patients, their families and carers, as well as to the medical community.